Christina Rolling: CAR T-Cell Therapy and Coagulation Disturbances Understanding Severe Hypofibrinogenemia
Christina Rolling, Specialist in Internal Medicine and Hematology and Oncology at University Medical Center Hamburg-Eppendorf, shared a post on LinkedIn about a recent article, she and her colleagues co-authored, published in Haematologica, adding:
“Excited to share our new publication on coagulation disturbances in patients undergoing CAR T-cell therapy!
We found that severe hypofibrinogenemia (fibrinogen lower 1 g/L) is a frequent finding, particularly in patients with lymphoma receiving tocilizumab for cytokine release syndrome (CRS).
Both increased fibrinogen consumption due to coagulation activation and reduced fibrinogen synthesis following IL-6 receptor blockade may contribute to CAR T-cell therapy-associated hypofibrinogenemia.
Interestingly, among patients with non-Hodgkin lymphoma receiving axi-cel, higher peak CAR T-cell levels were associated with lower fibrinogen nadirs and greater CRS severity.
This was a fantastic team effort! A huge thank you to everyone involved for the excellent collaboration!”
Title: Dynamics and clinical significance of coagulation abnormalities following CAR T-cell therapy
Authors: Christina Charlotte Rolling, Nigar Mammadova, Catherina Lück, Rolf Krause, Lennart Beckmann, Jochim Reinert, Carolina Berger, Boris Fehse, Florian Langer, Francis Ayuk

Stay updated with Hemostatis Today.
-
Nov 19, 2026, 09:34Dahlia R.: Immature Platelet Fraction Understanding the Cause of Low Platelet Counts
-
Nov 19, 2026, 07:00Rucha Patil: Highlights in Science and Collaboration at Haematocon 2026
-
Nov 19, 2026, 06:20Suvro Sankha Datta: AABB Releases the 8th Edition of Molecular Testing Standards
-
Nov 19, 2026, 05:54Global Collaboration in Hemostasis – ISTH
-
Nov 19, 2026, 05:40Pete Stibbs: Advancing Treatment Strategies in Venous Disease
-
Nov 19, 2026, 05:31Lance Reed: One Donation, Multiple Lives
-
Nov 19, 2026, 05:20ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders – HITh
-
Nov 19, 2026, 04:48Antiphospholipid Antibodies and Stroke Management – RPTH
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency